1-4 of 4
María Jesús Vidal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of Autologous Stem-Cell Transplantation in Patients with Relapsed or Refractory Aggressive B-Cell Lymphoma in the Rituximab Era. A Multicenter Geltamo Study.

Alba María Redondo, Alejandro Martín, Helena Pomares, María Jesús Vidal, María Jesús Pascual, Beatriz Quereda, Juan Manuel Sancho, Sr., MD, Joaquín Díaz-Mediavilla, Javier López, Eulogio Conde, MD, PhD, Isidro Jarque, MD, Natalia Alonso, María José Ramirez, María José Sayas, María José Requena, Antonio Salar, MD, José David González, MD, Eva González-Barca, MD, PhD, Reyes Arranz, Jesús F San Miguel, Dolores Caballero, MD
Journal: Blood
Blood (2012) 120 (21): 3142.
https://doi.org/10.1182/blood.V120.21.3142.3142
Published: 2012
Journal Articles

Predictive Value for Event-Free Survival of Interim 18F-FDG-PET In Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 6 Cycles of Dose-Dense R-CHOP-14 Immunochemotherapy Plus Pegfilgrastim as First-Line Treatment: An Open-Label Clinical Trial In Spain.

Eva González-Barca, Miguel Canales, MD, PhD, María Jesús Vidal, Albert Oriol, Antonio Salar, Joan Bargay, Montse Cortés, Juan Coya, José Francisco Tomás, Andrés López, José Javier Sánchez, Eva Donato, Andrés Llorente, Secundino Ferrer, Dolores Caballero
Journal: Blood
Blood (2010) 116 (21): 2793.
https://doi.org/10.1182/blood.V116.21.2793.2793
Published: 2010
Journal Articles

Interim and End-of-Treatment 18F-FDG-PET Evaluation of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 6 Cycles of Dose-Dense R-CHOP-14 Immunochemotherapy Plus Pegfilgrastim for First-Line Treatment: An Open-Label Clinical Trial in Spain.

Eva Gonzalez-Barca, Miguel Canales, Antonio Salar, Albert Oriol, María Jesús Vidal, Joan Bargay, Montse Cortés, J. Coya, Jose Francisco Tomas, Andrés López, José Javier Sánchez, Eva Donato, Andrés Llorente, Secundino Ferrer, Dolores Caballero
Journal: Blood
Blood (2009) 114 (22): 3692.
https://doi.org/10.1182/blood.V114.22.3692.3692
Published: 2009
Journal Articles

Therapeutic Compliance and Efficacy of Dose-Dense R-CHOP-14 Immunochemotherapy Plus Pegfilgrastim for First-Line Treatment of Low Risk Diffuse Large B-Cell Lymphoma Patients: Preliminary Results of An Open-Label Clinical Trial in Spain

Eva Gonzalez-Barca, Sr., Miguel Canales, III, Antonio Salar, MD, PhD, Secundino Ferrer, Joan Bargay, S. Grande, Santiago Gardella, María Jesús Vidal, Albert Oriol, MD, A. López, J. García, Jl Bello, Fj Tomás, Javier Briones, Dolores Caballero
Journal: Blood
Blood (2008) 112 (11): 4943.
https://doi.org/10.1182/blood.V112.11.4943.4943
Published: 2008